Eli Lilly SVP Zakrowski sells 2,000 company shares

ELI LILLY & Co officer Donald A. Zakrowski, SVP, Finance, & CAO, reported selling 2,000 shares of common stock on 2026-08-10 at an average price of $1,185.01 per share in an open-market transaction.

Rhea-AI Filing Summary

ELI LILLY & Co officer Donald A. Zakrowski, SVP, Finance, & CAO, reported selling 2,000 shares of common stock on 2026-08-10 at an average price of $1,185.01 per share in an open-market transaction. After this sale, he held 1,525.89 shares directly and 1,734.73 shares indirectly through a 401(k). The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026.

Insider Trade Summary 10b5-1

Net Seller: 2,000 shares

Net Sell 2 txns

Insider Zakrowski Donald A

Role SVP, Finance, & CAO

Sold 2,000 shs ($2.37M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	2,000	$1,185.01	$2.37M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,525.89 shares (Direct); Common Stock — 1,734.73 shares (Indirect, 401(k))

Footnotes (1)

1. F1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026.

Key Figures

Shares sold: 2,000 shares Sale price: $1,185.01 per share Direct holdings after sale: 1,525.89 shares +2 more

5 metrics

Shares sold 2,000 shares Common stock sold on 2026-08-10 by Donald A. Zakrowski

Sale price $1,185.01 per share Average price for the 2,000 LLY shares sold

Direct holdings after sale 1,525.89 shares Direct common stock held by Zakrowski following the transaction

Indirect 401(k) holdings 1,734.73 shares Indirect common stock held through a 401(k) after the transaction

10b5-1 plan adoption date May 11, 2026 Date Zakrowski adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, Form 4, indirect ownership, 401(k)

4 terms

Rule 10b5-1 trading plan regulatory

"The transaction was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"reported in a Form 4 insider transaction filing for Eli Lilly"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

indirect ownership financial

"shares indirectly through a 401(k) indicating indirect ownership classification"

401(k) financial

"1,734.73 shares indirectly through a 401(k) plan"

A 401(k) is a type of retirement savings plan offered by employers that allows workers to set aside a portion of their paycheck before taxes are taken out. The money saved in a 401(k) can grow over time through investments, helping individuals build funds for their future retirement. It matters to investors because it provides a tax-advantaged way to save and invest for long-term financial security.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LLY executive Donald A. Zakrowski report?

Donald A. Zakrowski reported selling 2,000 shares of Eli Lilly common stock on 2026-08-10 at an average price of $1,185.01 per share in an open-market transaction under a Rule 10b5-1 trading plan.

How many Eli Lilly (LLY) shares does Donald A. Zakrowski hold after this Form 4?

Following the reported sale, Donald A. Zakrowski held 1,525.89 Eli Lilly common shares directly and 1,734.73 shares indirectly through a 401(k) plan, as disclosed in the Form 4 filing.

Was the LLY insider sale by Donald A. Zakrowski under a Rule 10b5-1 plan?

Yes. The sale of 2,000 shares by Donald A. Zakrowski was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026, and the Rule 10b5-1 checkbox was affirmed.

What price did the LLY insider receive for the shares sold on 2026-08-10?

The reported sale by Donald A. Zakrowski of 2,000 LLY shares on 2026-08-10 was executed at an average price of $1,185.01 per share, according to the Form 4 transaction details.

What roles does Donald A. Zakrowski hold at Eli Lilly (LLY) in this Form 4?

In the Form 4, Donald A. Zakrowski is identified as an officer of Eli Lilly, serving as SVP, Finance, & CAO, and is not listed as a director or 10% beneficial owner.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 04:32 PM Accepted by SEC EDGAR 08/11/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zakrowski Donald A

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS INDIANA 46285

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Finance, & CAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/10/2026		S		2,000(1)	D	$1,185.01	1,525.89	D
Common Stock								1,734.73	I	401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026.

Remarks:

	/s/ Jonathan Groff for Donald A. Zakrowski, pursuant to authorization on file	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)